Biologists have succeeded in obtaining an unprecedented view of a type of brain-cell receptor that is implicated in a range of neurological illnesses, including Alzheimer's disease, Parkinson's disease, depression, schizophrenia, autism, and ischemic injuries associated with stroke. The team's atomic-level picture of the intact NMDA receptor should serve as template and guide for the design of therapeutic compounds.